Headline News about Tema GLP-1, Obesity & Cardiometabolic ETF
![](https://cdn.benzinga.com/files/images/story/2024/07/18/Ozempic-and-other-drugs-for-weight-loss.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/07/07/Valparaiso-In-Usa---March-21--2024-Wegov.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/06/A1-cholesterolscrub-070124-EGessel.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/29/weight-loss-Photo-by-Vidmir-Rais-via-Pix.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/10/Stock-drugTest-01-adobe.jpg)
![](https://images.pexels.com/photos/5716001/pexels-photo-5716001.jpeg?auto=compress&cs=tinysrgb&dpr=1&w=500)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/29/screenshot_2024-01-29_at_8.05.02_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/weight-loss-shutter2.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Yuri-Tema.jpeg?width=1200&height=800&fit=crop)
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads
December 01, 2023
Via Benzinga
Topics
ETFs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.